Besides PI3K/Akt signalling, dysregulation of mitogen-activated protein kinase (MAPK) signalling, mediated by OPN, also shows a major role in cancer-acquired resistance to both targeted and chemotherapeutic drugs. Here, AKT1 is linked to cancer.